Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-β1) in patients with gastric cancer

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Szkaradkiewicz, Andrzej ^a   Karpiński, Tomasz M ^a   Drews, Micha ^a   Borejsza Wysocki, MacIej ^a   Majewski, Przemysaw ^a   Andrzejewska, Ewa ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; IL10 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER STAGING; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NATURAL KILLER CELL; PROTEIN BLOOD LEVEL; STOMACH BIOPSY; STOMACH CANCER; AGED; BLOOD; CASE CONTROL STUDY; HELICOBACTER PYLORI; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; STOMACH TUMOR; TUMOR CELL CULTURE;

HELICOBACTER PYLORI;

AGED; CASE-CONTROL STUDIES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-10; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 77952519772     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/901564     Document Type: Article

References (32)

1. Colucci F., Caligiuri M. A., Di Santo J. P., What does it take to make a natural killer? Nature Reviews Immunology 2003 3 5 413 425
2. Soloski M. J., Recognition of tumor cells by the innate immune system Current Opinion in Immunology 2001 13 2 154 162
3. Takeuchi H., Maehara Y., Tokunaga E., Koga T., Kakeji Y., Sugimachi K., Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis American Journal of Gastroenterology 2001 96 2 574 578
4. Moore K. W., de Waal Malefyt R., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor Annual Review of Immunology 2001 19 683 765
5. Mege J.-L., Meghari S., Honstettre A., Capo C., Raoult D., The two faces of interleukin 10 in human infectious diseases The Lancet Infectious Diseases 2006 6 9 557 569
6. Letterio J. J., Roberts A. B., Regulation of immune responses by TGF-Annual Review of Immunology 1998 16 137 161
7. Kingsley D. M., The TGF-superfamily: new members, new receptors, and new genetic tests of function in different organisms Genes and Development 1994 8 2 133 146
8. De Vita F., Orditura M., Galizia G., Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies Cancer 1999 86 10 1936 1943
9. Nakamura M., Katano M., Kuwahara A., Transforming growth factor 1 (TGF-1) is a preoperative prognostic indicator in advanced gastric carcinoma British Journal of Cancer 1998 78 10 1373 1378
10. IARC Working Group, Schistosomes, liver flukes and Helicobacter pylori: views and expert opinion of IARC working group on the evaluation of carcinogenic risks to humans International Agency for Research on Cancer 1994 61 177 240
11. Matysiak-Budnik T., Mgraud F., Helicobacter pylori infection and gastric cancer European Journal of Cancer 2006 42 6 708 716
12. Hafsi N., Voland P., Schwendy S., Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro Journal of Immunology 2004 173 2 1249 1257
13. Hamilton S. R., Aaltonen A., Pathology and Genetics of Tumours of the Digestive System: Tumours of the Stomach 2000 Lyon, France IARC Press
14. Yamaguchi Y., Takashima I., Funakoshi M., Kawami H., Toge T., Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor In Vivo 1994 8 3 279 284
15. Fortis C., Foppoli M., Gianotti L., Increased interleukin-10 serum levels in patients with solid tumours Cancer Letters 1996 104 1 1 5
16. Cai G., Kastelein R. A., Hunter C. A., IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-when combined with IL-18 European Journal of Immunology 1999 29 9 2658 2665
17. Mocellin S., Panelli M., Wang E., IL-10 stimulatory effects on human NK cells explored by gene profile analysis Genes and Immunity 2004 5 8 621 630
18. Taylor A., Verhagen J., Blaser K., Akdis M., Akdis C. A., Mechanisms of immune suppression by interleukin-10 and transforming growth factor-: the role of T regulatory cells Immunology 2006 117 4 433 442
19. Wen Q. S., Zhang G. Z., Kong X. T., Modulation effect of cimetidine on the production of IL-2 and interferon-in patients with gastric cancer Chinese Journal of Oncology 1994 16 4 299 301
20. Vosshenrich C. A. J., Samson-Villger S. I., Di Santo J. P., Distinguishing features of developing natural killer cells Current Opinion in Immunology 2005 17 2 151 158
21. Chan S. H., Perussia B., Gupta J. W., Induction of interferon production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers Journal of Experimental Medicine 1991 173 4 869 879
22. Thong-Ngam D., Tangkijvanich P., Lerknimitr R., Mahachai V., Theamboonlers A., Poovorawan Y., Diagnostic role of serum interleukin-18 in gastric cancer patients World Journal of Gastroenterology 2006 12 28 4473 4477
23. Konturek P. C., Kania J., Konturek J. W., Nikiforuk A., Konturek S. J., Hahn E. G., H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR and impaired apoptosis in gastric carcinogenesis Medical Science Monitor 2003 9 7 SR53 SR66
24. Zambon C.-F., Basso D., Navaglia F., Pro-and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome Cytokine 2005 29 4 141 152
25. El-Omar E.M., Rabkin C. S., Gammon M. D., Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms Gastroenterology 2003 124 5 1193 1201
26. Yun C. H., Lundgren A., Azem J., Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production Infection and Immunity 2005 73 3 1482 1490
27. Cooper M. A., Fehniger T. A., Caligiuri M. A., The biology of human natural killer-cell subsets Trends in Immunology 2001 22 11 633 640
28. Jacobs R., Hintzen G., Kemper A., CD56 bright cells differ in their KIR repertoire and cytotoxic features from CD56 dim NK cells European Journal of Immunology 2001 31 10 3121 3126
29. Ren Z., Pang G., Clancy R., Gastric carcinoma: T-cell response and vascularity. Shift of the gastric T-cell response in gastric carcinoma Journal of Gastroenterology and Hepatology 2001 16 2 142 148
30. Vagenas K., Spyropoulos C., Gavala V., Tsamandas A. C., TGF 1, TGF 2, and TGF 3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival Journal of Surgical Research 2007 139 2 182 188
31. Gleizes P.-E., Munger J. S., Nunes I., TGF-latency: biological significance and mechanisms of activation Stem Cells 1997 15 3 190 197
32. Wakefield L. M., Letterio J. J., Chen T., Transforming growth factor-1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer Clinical Cancer Research 1995 1 1 129 136